SG Americas Securities
CPXX

SG Americas Securities’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

SG Americas Securities’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-436,207
Closed -$13.2M – 3628
2016
Q2 		$13.2M Buy
+436,207
New +$8.85M 0.09% 167

SG Americas Securities's CPXX Position: Q3 2016 in Review

SG Americas Securities sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 436,207 shares — an estimated $13.2M sold.

SG Americas Securities first reported a position in CPXX in Q2 2016 and held it in 1 quarter. The position peaked at $13.2M in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • SG Americas Securities reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • SG Americas Securities sold 436,207 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $13.2M.
  • SG Americas Securities first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q2 2016 and held it in 1 quarter.
  • SG Americas Securities's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $13.2M in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on SG Americas Securities's 13F filing for Q3 2016, filed 8 Nov 2016.